Skip to content
healthcare.dev

Sunlenca

NDC 61958-3001, LENACAPAVIR SODIUM, tablet, film coated, from Gilead Sciences, Inc..

Product NDC
61958-3001
Status
Listed
Labeler
Gilead Sciences, Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA215974
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/61958-3001 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LENACAPAVIR SODIUM300 mg/1

Pharmacologic classes

Breast Cancer Resistance Protein Inhibitors [MoA]; Cytochrome P450 3A Inhibitors [MoA]; HIV Capsid Inhibitors [MoA]; Human Immunodeficiency Virus 1 Capsid Inhibitor [EPC]; P-Glycoprotein Inhibitors [MoA]

Package NDCNDC-11Package
61958-3001-1619583001011 POUCH in 1 CARTON (61958-3001-1) / 1 BLISTER PACK in 1 POUCH / 4 TABLET, FILM COATED in 1 BLISTER PACK
61958-3001-2619583001021 POUCH in 1 CARTON (61958-3001-2) / 1 BLISTER PACK in 1 POUCH / 5 TABLET, FILM COATED in 1 BLISTER PACK
61958-3001-3619583001034 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (61958-3001-3)

Linked data

RxNorm, label and prices

Use it

Look up 61958-3001 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/61958-3001 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 61958-3001. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.